Permascand has received an order for high-efficiency electrodes for advanced alkaline electrolysis from a new European customer within the hydrogen business. The customer has placed a prototype order of SEK 3.3 million, with the intention of it being...

Third quarter 2023 (Q3 2022) January–September 2023 (January–September 2022) Events during the third quarter of 2023 Significant events after the end of the reporting period CEO comment The third quarter of the year was characterised by a...

Permascand has received an order from a global leader in hydrogen technology for high-efficiency electrodes for advanced alkaline electrolysis. The order value amounts to approximately SEK 17 million and will be included as order intake in the fourth...

Permascand will publish its Q3 2023 interim report on 9 November 2023 at 07:45 CET. In connection with this, Permascand invites investors, analysts and media to a conference call and webcast on the same day at 10:30 CET. The presentation will be held...

Permascand has signed a Letter of Intent (LOI) with a leading green hydrogen technology provider and system integrator concerning the manufacturing of high-performance electrodes for advanced alkaline electrolysis, strengthening the company’s existing...

Permascand has received two orders from one of the world's largest commodity trading companies regarding aftermarket services in electrowinning, within the Electrification & Renewables segment. The order value totals approximately SEK 130 million...

Permascand enters a strategic membership in Hydrogen Europe, a leading organisation in the world of hydrogen. Joining the organisation will enhance Permascand’s presence in the European green hydrogen ecosystem and support the company’s strategy...

Second quarter 2023 (Q2 2022) January–June 2023 (Q2 2022) Events during the second quarter of 2023 CEO comment The second quarter of the year was characterised by continued changes to the revenue mix, with growth in the Electrification & Renewables...

Permascand will publish its Q2 2023 interim report on 16 August 2023 at 07:45 CEST. In connection with this, Permascand invites investors, analysts and media to a conference call and webcast on the same day at 10:30 CEST. The presentation will be held...

Permascand has signed a collaboration and supply agreement with Chemetry, a company focused on developing lower energy technologies in the chemical space, based in Moss Landing, California. As part of the agreement, Permascand has acquired shares in Chemetry...

Interim report January-March 2023 First quarter 2023 (Q1 2022) Events during the first quarter of 2023 CEO comment This quarter, we focused on strengthening our operational capacity for the future. The shift in our revenue mix is increasingly evident...

At the Annual General Meeting in Permascand Top Holding AB, Reg. No. 559227-6124 (the “company”), on 9 May 2023 in Ljungaverk, it was resolved in accordance with the below. For more detailed information on the content of the resolutions, please...

Permascand will publish its Q1 2023 interim report on 10 May 2023 at 07:45 CEST. In connection with this, Permascand invites investors, analysts and media to a conference call and webcast on the same day at 10:30 CEST. The presentation will be held by...

Permascand communicated in connection with the Year-end report on February 9, 2023, that the company expects declining revenues in Water Treatment. The situation has been further reinforced, and the company is experiencing significantly weaker and declining...

Permascand’s Annual Report and Sustainability Report for 2022 have been published and are available on the company’s website at https://permascand.com/investors/ For more information, please contact: Peter Lundström, CEOTel: +46 73-028...

The shareholders of Permascand Top Holding AB, Reg. No. 559227-6124 (”Permascand” or the ”company”), are hereby summoned to the Annual General Meeting on Tuesday, 9 May 2023, 15.00 CEST, at Ljungaverks Folkets Hus, Folketshusvägen...

Permascand has appointed Nariman Askarieh as interim Global Chief Commercial Officer (CCO). Nariman joins from his most recent role as Nordic Commercial Director at the global medical technology company Stryker and will assume his role on March 15, 2023...

Year-end report 2022 Q4 2022 (Q4 2021) Jan–Dec 2022 (Jan–Dec 2021) Events during the fourth quarter of 2022 CEO comment The strength of Permascand’s business clearly showed through in the fourth quarter of 2022, where profitable growth...

Permascand will publish its year-end report 2022 on 9 February 2023 at 07:45 CET. In connection with this, Permascand invites investors, analysts and media to a conference call and webcast on the same day at 10:30 CET. The presentation will be held by...

Permascand has signed a Master Supply Agreement to deliver service and refurbishment of electrochemical cells to a significant client. The business relationship is well established for a long time. The estimated value of the agreement is in the range...